MDT
Medtronic PLC
Medtronic PLC historical holders
total: 14
Pzena Investment Management Medtronic PLC transactions over time
- Total transactions:
- 17
- New positions:
- 2
- Sold out:
- 1
- Added:
- 9
- Reduced:
- 5
- Held since:
- 2023 Q1
- Held for:
- 14 quarters
- Latest activity:
- 2026 Q2
Richard Pzena has been an institutional investor in Medtronic PLC (MDT) since 2016 Q4. According to 2026 Q2 report, Richard Pzena holds 3,147,999 shares with a market value of roughly $246.27M representing 0.72% of their equity portfolio. The fund/company first acquired MDT in 2016 Q4, initially purchasing 4,287 shares. Richard Pzena later completely sold out the position and reinvested in MDT again in 2023 Q1. Since the initial investment, Pzena Investment Management has made 16 more transactions in this position.
Does Richard Pzena still hold MDT?
Yes, Richard Pzena continues to hold Medtronic PLC (MDT). According to their 2026 Q2 report, they maintain a position of 3,147,999 shares valued at approximately $246.27M, representing 0.72% of their equity portfolio.
When did Richard Pzena first invest in MDT?
Richard Pzena first invested in Medtronic PLC (MDT) in 2016 Q4 at the reported quarter-end price of $71.15 per share, acquiring 4,287 shares in their initial purchase.
What is Richard Pzena's average cost basis for MDT?
Based on historical transaction data, Richard Pzena's estimated cost basis for Medtronic PLC (MDT) is approximately $82.22 per share. This represents their average reported price* across all buy transactions.
Has Richard Pzena reinvested in MDT after selling?
Yes, Richard Pzena has shown renewed interest in Medtronic PLC (MDT). After completely selling their position, they reinitiated an investment in 2023 Q1, demonstrating continued conviction in this ticker.
Estimated cost basis*
- Weighted AVG buy price:
- $82.22
- Weighted AVG sell price:
- $94.56
MDT transactions history by Pzena Investment Management
17 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
0.72%
|
3,147,999
|
$78.23
|
$246,267,980
|
-0.29% (-9,016)
|
-0%
|
|
2026 Q1
|
0.89%
|
3,157,015
|
$86.65
|
$273,555,338
|
-1.92% (-61,837)
|
-0.02%
|
|
2025 Q4
|
0.93%
|
3,218,852
|
$96.06
|
$309,202,963
|
-45.70% (-2,709,234)
|
-0.84%
|
|
2025 Q3
|
1.82%
|
5,928,086
|
$95.24
|
$564,590,886
|
-33.06% (-2,927,205)
|
-0.91%
|
|
2025 Q2
|
2.51%
|
8,855,291
|
$87.17
|
$771,915,739
|
+5.59% (+469,069)
|
+0.13%
|
|
2025 Q1
|
2.63%
|
8,386,222
|
$89.86
|
$753,585,918
|
+2.08% (+171,205)
|
+0.05%
|
|
2024 Q4
|
2.23%
|
8,215,017
|
$79.88
|
$656,215,530
|
-4.29% (-367,976)
|
-0.09%
|
|
2024 Q3
|
2.49%
|
8,582,993
|
$90.03
|
$772,726,839
|
+3.32% (+275,870)
|
+0.08%
|
|
2024 Q2
|
2.30%
|
8,307,123
|
$78.71
|
$653,853,624
|
+8.32% (+637,931)
|
+0.18%
|
|
2024 Q1
|
2.29%
|
7,669,192
|
$87.15
|
$668,370,086
|
+2.25% (+168,630)
|
+0.05%
|
|
2023 Q4
|
2.32%
|
$82.38
|
+30.89% (+1,769,985)
|
|||
|
2023 Q3
|
1.93%
|
$78.36
|
+112.78% (+3,037,394)
|
|||
|
2023 Q2
|
1.01%
|
$88.10
|
+129.51% (+1,519,728)
|
|||
|
2023 Q1
|
0.41%
|
$80.62
|
new
|
|||
|
2017 Q2
|
0.00%
|
$80.48
|
-100% (-4,560)
|
|||
|
2017 Q1
|
0.00%
|
$80.48
|
+6.37% (+273)
|
|||
|
2016 Q4
|
0.00%
|
$71.15
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.